The Board announced that the Shenzhen Neptunus Interlong Bio-technique Company Limited entered into the 2020 Sales Management Service Agreement with Neptunus Pharmaceutical, a fellow subsidiary and a connected person of the company on 8 June 2020, pursuant to which the company has agreed to provide sales management service of pharmaceutical products to Neptunus Pharmaceutical for the period from the Effective Date to 31 December 2022. The 2019 Sales Management Service Announcement in connection with the entering into of the 2019 Sales Management Service Agreement between Neptunus Changjian and Neptunus Pharmaceutical, pursuant to which Neptunus Changjian has agreed to provide sales management service of pharmaceutical products to Neptunus Pharmaceutical for the period from 1 January 2019 to 31 December 2021. As the sales management service segment under the 2019 Sales Management Service Agreement will be taken over by the company from Neptunus Changjian, the parties to the 2019 Sales Management Service Agreement has agreed to terminate the 2019 Sales Management Service Agreement with effect from the Effective Date.